Search Results

Filter
  • 1-10 of  28,277 results for ""Antibodies, Neutralizing""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Human antibodies neutralizing the alpha-latrotoxin of the European black widow.

  • Authors : Ruschig M; Departments of Biotechnology and Medical Biotechnology, Institute for Biochemistry, Biotechnology and Bioinformatics, Technische Universität Braunschweig, Braunschweig, Germany.; Nerlich J

Subjects: Black Widow Spider*/Black Widow Spider*/Black Widow Spider*/immunology ; Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/immunology ; Spider Venoms*/Spider Venoms*/Spider Venoms*/immunology

  • Source: Frontiers in immunology [Front Immunol] 2024 Jun 12; Vol. 15, pp. 1407398. Date of Electronic Publication: 2024 Jun 12 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Isolation and characterization of Hc-targeting chimeric heavy chain antibodies neutralizing botulinum neurotoxin type B.

  • Authors : Jiang Y; Beijing Institute of Biotechnology, Beijing, China.; Wang R

Subjects: Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/immunology ; Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/immunology ; Botulism*/Botulism*/Botulism*/immunology

  • Source: Frontiers in immunology [Front Immunol] 2024 Apr 30; Vol. 15, pp. 1380694. Date of Electronic Publication: 2024 Apr 30 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Prophylactic efficacy of an intranasal spray with 2 synergetic antibodies neutralizing Omicron.

  • Authors : Zhang X; CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China.; Luo F

Subjects: Nasal Sprays* ; Antibodies, Neutralizing*; Animals

  • Source: JCI insight [JCI Insight] 2024 Apr 08; Vol. 9 (7). Date of Electronic Publication: 2024 Apr 08.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Structure-guided mutations in CDRs for enhancing the affinity of neutralizing SARS-CoV-2 nanobody.

  • Authors : Singh V; Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Uttarakhand, India.; Bhutkar M

Subjects: Single-Domain Antibodies*/Single-Domain Antibodies*/Single-Domain Antibodies*/genetics ; Single-Domain Antibodies*/Single-Domain Antibodies*/Single-Domain Antibodies*/chemistry ; Single-Domain Antibodies*/Single-Domain Antibodies*/Single-Domain Antibodies*/immunology

  • Source: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2024 Nov 19; Vol. 734, pp. 150746. Date of Electronic Publication: 2024 Sep 26.Publisher: Elsevier Country of Publication: United States NLM ID: 0372516 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Immunogenicity of mRNA vs. BBV152 vaccine boosters against Omicron subvariants: Final results from Phase B of the PRIBIVAC study, a randomized clinical trial.

Subjects: COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/immunology ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/administration & dosage ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology SARS-CoV-2 variants

  • Source: Vaccine [Vaccine] 2024 Nov 14; Vol. 42 (25), pp. 126275. Date of Electronic Publication: 2024 Sep 05.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Humoral immune response against SARS-CoV-2 after adapted COVID-19 vaccine schedules in healthy adults: The IMCOVAS randomized clinical trial.

  • Authors : Steenackers K; Centre for Evaluation of Vaccination, University of Antwerp, Drie Eikenstraat 663, 2650 Edegem, Belgium.; Hanning N

Subjects: Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/blood ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/immunology ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology

  • Source: Vaccine [Vaccine] 2024 Nov 14; Vol. 42 (25), pp. 126117. Date of Electronic Publication: 2024 Jul 16.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A getah virus-like-particle vaccine provides complete protection from viremia and arthritis in wild-type mice.

  • Authors : Miao Q; Laboratory of Virology, Wageningen University & Research, Wageningen, The Netherlands; Shanghai Veterinary Research Institute Chinese Academy of Agricultural Sciences, China. Electronic address: .

Subjects: Vaccines, Virus-Like Particle*/Vaccines, Virus-Like Particle*/Vaccines, Virus-Like Particle*/immunology ; Vaccines, Virus-Like Particle*/Vaccines, Virus-Like Particle*/Vaccines, Virus-Like Particle*/administration & dosage ; Viremia*/Viremia*/Viremia*/prevention & control

  • Source: Vaccine [Vaccine] 2024 Nov 14; Vol. 42 (25), pp. 126136. Date of Electronic Publication: 2024 Jul 14.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Generation of a Nonbilayer Lipid Nanoenvironment after Epitope Binding Potentiates Neutralizing HIV-1 MPER Antibody.

  • Authors : Insausti S; Instituto Biofisika (CSIC, UPV/EHU), University of the Basque Country (UPV/EHU), P.O. Box 644, Bilbao 48080, Spain.; Department of Biochemistry and Molecular Biology, University of the Basque Country (UPV/EHU), P.O. Box 644, Bilbao 48080, Spain.

Subjects: HIV-1*/HIV-1*/HIV-1*/immunology ; HIV-1*/HIV-1*/HIV-1*/chemistry ; Epitopes*/Epitopes*/Epitopes*/immunology

  • Source: ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2024 Nov 06; Vol. 16 (44), pp. 59934-59948. Date of Electronic Publication: 2024 Oct 24.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101504991 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Comparative study of neutralizing antibodies titers in response to different types of COVID-19 vaccines among a group of egyptian healthcare workers.

  • Authors : Maher S; Immunology Department, Theodor Bilharz Research Institute, Giza, Egypt.; Assaly NME

Subjects: Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/blood ; Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/immunology ; Health Personnel* SARS-CoV-2 variants

  • Source: Virology journal [Virol J] 2024 Nov 05; Vol. 21 (1), pp. 277. Date of Electronic Publication: 2024 Nov 05.Publisher: BioMed Central Country of Publication: England NLM ID: 101231645 Publication Model: Electronic Cited Medium: Internet ISSN: 1743-422X

Record details

×
  • 1-10 of  28,277 results for ""Antibodies, Neutralizing""